AstraZeneca stock dives 9% after heart drug trial misses target

--------------------------------------------------------------------
Source: CNBC
Published: 2026-07-09 17:34 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, Law & Courts, Drugs, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
Shares of AstraZeneca fell as much as 9% after a late stage clinical trial for an experimental heart disease failed to meet its target.
--------------------------------------------------------------------
>>> Read full article at CNBC <<<
<-- Back to Home
< >
[Close]